Yvonne Ying Ru Ng

Yvonne Ying Ru Ng

Auto-generated profile, based on publicly available information

Yvonne Ying Ru Ng

Department of Colorectal Surgery, Singapore General Hospital, Singapore

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
IWIan Wee
Ian Wee
CKChee Hoe Koo
Chee Hoe Koo
ISIsaac Seow-En
Isaac Seow-En
YNYvonne Ying Ru Ng
Yvonne Ying Ru Ng
WLWenjie Lin
Wenjie Lin
ETEmile John Kwong-Wei Tan
Emile John Kwong-Wei Tan
Purpose: This study compared the short- and long-term clinical outcomes of laser hemorrhoidoplasty (LH) vs. conventional hemorrhoidectomy (CH) in patients with grade II/III hemorrhoids.Methods: PubMed/Medline and the Cochrane Library were searched for randomized and nonrandomized studies comparing LH against CH in grade II/III hemorrhoids. The primary outcomes included postoperative use of analgesia, postoperative morbidity (bleeding, urinary retention, pain, thrombosis), and time of return to work/daily activities.Results: Nine studies totaling 661 patients (LH, 336 and CH, 325) were included. The LH group had shorter operative time (P<0.001) and less intraoperative blood loss (P<0.001). Postoperative pain was lower in the LH group, with lower postoperative day 1 (mean difference [MD], –2.09; 95% confidence interval [CI], –3.44 to –0.75; P=0.002) and postoperative day 7 (MD, –3.94; 95% CI, –6.36 to –1.52; P=0.001) visual analogue scores and use of analgesia (risk ratio [RR], 0.59; 95% CI, 0.42–0.81; P=0.001). The risk of postoperative bleeding was also lower in the LH group (RR, 0.18; 95% CI, 0.12– 0.28; P0.999) and prolapse (P=0.240), and the likelihood of complete resolution at 12 months, were similar (P=0.240).Conclusion: LH offers more favorable short-term clinical outcomes than CH, with reduced morbidity and pain and earlier return to work or daily activities. Medium-term symptom recurrence at 12 months was similar. Our results should be verified in future well-designed trials with larger samples.

16 November 2023 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Open access
ISIsaac Seow-En
Isaac Seow-En
JWJingting Mbbs Wu
Jingting Mbbs Wu
ITIvan En-Howe Mba Tan
Ivan En-Howe Mba Tan
YZYun Zhao
Yun Zhao
ASAaron WEI MING Seah
Aaron WEI MING Seah
ETEmile Mbbs Kwong-Wei Tan
Emile Mbbs Kwong-Wei Tan
Introduction: Total mesorectal excision (TME) with delayed coloanal anastomosis (DCAA) is surgical option for low rectal cancer, replacing conventional immediate coloanal anastomosis (ICAA) with bowel diversion. This study aimed to assess the outcomes of transanal TME (TaTME) with DCAA versus laparoscopic TME (LTME) with ICAA versus robotic TME (RTME) with ICAA. Methods: This was a retrospective propensity score-matched analysis of patients who underwent elective TaTME-DCAA between November 2021 and June 2022. Patients were propensity-score matched in a ratio of 1:3 to patients who underwent LTME-ICAA and RTME-ICAA from January 2019 to December 2020. Outcome measures were histopathologic results, postoperative morbidity, function, and inpatient costs. Results: Twelve patients in the TaTME-DCAA group were compared with 36 patients in the LTME-ICAA and RTME-ICAA groups each after propensity score matching. Histopathologic results and postoperative morbidity rates were statistically similar. Overall stoma-related complication rates in the ICAA groups were 11%. Median total length of hospital stays for TME plus stoma reversal surgery was similar across all techniques (10 vs. 10 vs. 9 days; P=0.532). Despite a significantly shorter duration of follow-up, bowel function after TaTME-DCAA was comparable to that of LTME-ICAA and RTME-ICAA. Overall median inpatient costs of TaTME-DCAA were comparable to LTME-ICAA and significantly cheaper than RTME-ICAA ($31,087 vs. $29,927 vs. $36,750; P=0.002). Conclusions: TaTME with DCAA is a feasible and safe technique compared with other minimally invasive methods of TME, while avoiding bowel diversion and stoma-related complications, as well as comparing favorably in terms of overall hospitalization costs.

27 August 2021 in Asian Journal of Endoscopic Surgery
Verified
Journal Article
Closed access
PDF file
YNYvonne Ying‐Ru Ng
Yvonne Ying‐Ru Ng
ETEmile John Kwong Wei Tan
Emile John Kwong Wei Tan
CFCherylin Fu
Cherylin Fu

27 August 2022 in Techniques in Coloproctology
Verified
Journal Article
Closed access
PDF file
ISIsaac Seow-En
Isaac Seow-En
YNY. Y.-R. Ng
Y. Y.-R. Ng
ITI. B. H. Tan
I. B. H. Tan
ETE. K.-W. Tan
E. K.-W. Tan

30 June 2024 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
STShih Jia Janice Tan
Shih Jia Janice Tan
ETEmile Kwong-Wei Tan
Emile Kwong-Wei Tan
YNYvonne Ying Ru Ng
Yvonne Ying Ru Ng
RSRehena Sultana
Rehena Sultana
JAJohn Carson Allen
John Carson Allen
ACAik Yong Chok
Aik Yong Chok
Purpose: We compared the incidence of venous thromboembolism (VTE) among Asian populations with localized colorectal cancer undergoing curative resection with and without the use of pharmacological thromboprophylaxis (PTP).Methods: A comprehensive literature search was undertaken to identify relevant studies published from January 1, 1980 to February 28, 2022. The inclusion criteria were patients who underwent primary tumor resection for localized nonmetastatic colorectal cancer; an Asian population or studies conducted in an Asian country; randomized controlled trials, case-control studies, or cohort studies; and the incidence of symptomatic VTE, deep vein thrombosis, and/or pulmonary embolism as the primary study outcomes. Data were pooled using a random-effects model. This study was registered in PROSPERO on October 11, 2020 (No. CRD42020206793).Results: Seven studies (2 randomized controlled trials and 5 observational cohort studies) were included, encompassing 5,302 patients. The overall incidence of VTE was 1.4%. The use of PTP did not significantly reduce overall VTE incidence: 1.1% (95% confidence interval [CI], 0%–3.1%) versus 1.9% (95% CI, 0.3%–4.4%; P = 0.55). Similarly, PTP was not associated with significantly lower rates of symptomatic VTE, proximal deep vein thrombosis, or pulmonary embolism.Conclusion: The benefit of PTP in reducing VTE incidence among Asian patients undergoing curative resection for localized colorectal cancer has not been clearly established. The decision to administer PTP should be evaluated on a case-bycase basis and with consideration of associated bleeding risks.

29 October 2022 in Anz Journal of Surgery
Verified
Journal Article
Closed access
WNWee Kiat Daniel Ng
Wee Kiat Daniel Ng
ACAik Yong Chok
Aik Yong Chok
YNYvonne Ying‐Ru Ng
Yvonne Ying‐Ru Ng
ISIsaac Seow-En
Isaac Seow-En
ETEmile Kwong‐Wei Tan
Emile Kwong‐Wei Tan